We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
-6.26%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.07B
AUM Growth
-$484M
(-19%)
Cap. Flow
-$243M
Cap. Flow
% of AUM
-11.71%
Top 10 Holdings %
Top 10 Hldgs %
39.78%
Holding
174
New
48
Increased
26
Reduced
40
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$61.5M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$53.8M |
| 3 |
PayPal
PYPL
|
+$44.3M |
| 4 |
PNK
Pinnacle Entertainment Inc.
PNK
|
+$34.6M |
| 5 |
Axalta
AXTA
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$65.6M |
| 2 |
Tyson Foods
TSN
|
+$57.2M |
| 3 |
SUNE
SUNEDISON, INC COM
SUNE
|
+$38.5M |
| 4 |
eBay
EBAY
|
+$29M |
| 5 |
Hilton Worldwide
HLT
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.1% |
| 2 | Consumer Staples | 7.63% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Industrials | 5.06% |
| 5 | Financials | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lexicon Pharmaceuticals
LXRX
$1.07B
| $5.64M | 0.27% |
+525,000
| New | +$5.73M |
|
|
ALPN
77
DELISTED
Alpine Immune Sciences Inc
ALPN
| $5.43M | 0.26% |
104,726
+23,476
| +29% | +$1.54M |
|
|
NVO
78
PUT
Novo Nordisk
NVO
$198B
| $5.42M | 0.26% |
+200,000
| New | +$5.66M |
|
79
Zevra Therapeutics
ZVRA
$622M
| $5.24M | 0.25% |
16,900
+2,837
| +20% | +$869K |
|
|
TSNU
80
DELISTED
Tyson Foods, Inc.
TSNU
| $5.13M | 0.25% |
100,000
-135,000
| -57% | -$6.96M |
|
|
VDTH
81
DELISTED
Videocon d2h Limited
VDTH
| $5.12M | 0.25% |
530,000
+45,000
| +9% | +$519K |
|
82
Eli Lilly
LLY
$1.03T
| $5.11M | 0.25% |
+61,100
| New | +$5.16M |
|
|
ENTL
83
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $4.87M | 0.23% |
270,000
+5,000
| +2% | +$111K |
|
84
PUT
Petrobras
PBR
$119B
| $4.83M | 0.23% |
+1,110,000
| New | +$6.77M |
|
85
Great Elm Group
GEG
$69M
| $4.74M | 0.23% |
545,021
| – | – |
|
86
Exelixis
EXEL
$14B
| $4.6M | 0.22% |
+820,000
| New | +$4.46M |
|
87
Starbucks
SBUX
$121B
| $4.51M | 0.22% |
79,298
-235,000
| -75% | -$13.2M |
|
|
88
CALL
Lexicon Pharmaceuticals
LXRX
$1.07B
| $4.3M | 0.21% |
+400,000
| New | +$4.37M |
|
|
IVTY
89
DELISTED
Invuity, Inc
IVTY
| $4.23M | 0.2% |
302,000
+26,000
| +9% | +$341K |
|
90
Hain Celestial
HAIN
$48.1M
| $4.13M | 0.2% |
80,000
-96,000
| -55% | -$6.08M |
|
91
Monolithic Power Systems
MPWR
$65.4B
| $4.12M | 0.2% |
+80,462
| New | +$3.99M |
|
|
EMWP
92
DELISTED
Eros Media World PLC
EMWP
| $4.08M | 0.2% |
7,500
-11,299
| -60% | -$7.22M |
|
|
LNKD
93
PUT
DELISTED
LinkedIn Corporation
LNKD
| $3.59M | 0.17% |
+18,900
| New | +$3.75M |
|
94
Lipocine
LPCN
$18.1M
| $3.49M | 0.17% |
17,353
-294
| -2% | -$68K |
|
95
CALL
Vanda Pharmaceuticals
VNDA
$311M
| $3.38M | 0.16% |
+300,000
| New | +$3.67M |
|
|
ATRS
96
DELISTED
Antares Pharma, Inc.
ATRS
| $3.34M | 0.16% |
1,965,738
+300,000
| +18% | +$588K |
|
97
CALL
Sarepta Therapeutics
SRPT
$1.71B
| $3.21M | 0.15% |
+100,000
| New | +$3.39M |
|
|
ABMD
98
DELISTED
Abiomed Inc
ABMD
| $3.15M | 0.15% |
33,900
-41,100
| -55% | -$3.62M |
|
|
IL
99
DELISTED
IntraLinks Holdings Inc.
IL
| $2.88M | 0.14% |
347,032
-170,605
| -33% | -$1.81M |
|
|
CEMP
100
PUT
DELISTED
Cempra, Inc.
CEMP
| $2.78M | 0.13% |
+100,000
| New | +$3.71M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Kingdon Capital Management held 174 positions worth $2.07B, down 19% from $2.56B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Kingdon Capital Management withdrew a net $243M in Q3 2015, closing 49 positions and reducing 40 holdings. Its most notable exit was eBay, an estimated $29M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Kingdon Capital Management opened a new position in Alphabet (Google) Class C worth $63.9M.
- Kingdon Capital Management's largest Q3 2015 buy was Alphabet (Google) Class C: 2,001,820 shares worth $63.9M.
- Kingdon Capital Management added most to ANACOR PHARMACEUTICALS INC COM in Q3 2015, an estimated $53.8M increase.
- Kingdon Capital Management's biggest Q3 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $65.6M.
- Kingdon Capital Management fully exited eBay in Q3 2015, selling an estimated $29M.
- Kingdon Capital Management's ten largest holdings make up 40% of its $2.07B portfolio in Q3 2015.
- Kingdon Capital Management opened 48 new positions and closed 49 in Q3 2015.
- Kingdon Capital Management's portfolio value fell 19% quarter-over-quarter to $2.07B.
Based on Kingdon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.